wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34297594-FF6C230E-2813-4719-AB17-7DA886B857C9
Q34297594-FF6C230E-2813-4719-AB17-7DA886B857C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34297594-FF6C230E-2813-4719-AB17-7DA886B857C9
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
P2860
Q34297594-FF6C230E-2813-4719-AB17-7DA886B857C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34297594-FF6C230E-2813-4719-AB17-7DA886B857C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2dcd0dbfda526de6015c1f88a06a204f8ea3363d
P2860
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib